Clinical and translational discovery

Keyphrases

Publications

volume 4, number 3, 2024

Oluwaferanmi Omidiran, Aashna Patel, Sarah Usman, Ishani Mhatre, Habiba Abdelhalim, William DeGroat, Rishabh Narayanan, Kritika Singh, Dinesh Mendhe, Zeeshan Ahmed
GWAS advancements to investigate disease associations and biological mechanisms. Clinical and translational discovery 4 (3) (2024)
Oluwaferanmi Omidiran, Aashna Patel, Sarah Usman, Ishani Mhatre, Habiba Abdelhalim, William DeGroat, Rishabh Narayanan, Kritika Singh, Dinesh Mendhe, Zeeshan Ahmed
GWAS advancements to investigate disease associations and biological mechanisms. Clinical and translational discovery 4 (3) (2024)

volume 4, number 4, 2024

Steffan T Nawrocki, Claudia M Espitia, Maria Janina Carrera Espinoza, Madison E Gamble, Sruthi Sureshkumar, Mengyang Chang, Wei Wang, Jennifer S Carew
Targeting autophagy: a promising approach for the treatment of breast cancer brain metastases. Clinical and translational discovery 4 (4) (2024)
Steffan T Nawrocki, Claudia M Espitia, Maria Janina Carrera Espinoza, Madison E Gamble, Sruthi Sureshkumar, Mengyang Chang, Wei Wang, Jennifer S Carew
Targeting autophagy: a promising approach for the treatment of breast cancer brain metastases. Clinical and translational discovery 4 (4) (2024)
Steffan T Nawrocki, Claudia M Espitia, Maria Janina Carrera Espinoza, Madison E Gamble, Sruthi Sureshkumar, Mengyang Chang, Wei Wang, Jennifer S Carew
Targeting autophagy: a promising approach for the treatment of breast cancer brain metastases. Clinical and translational discovery 4 (4) (2024)
Wei-Ling Tu, Mu-En Wang, Ming Chen
Tracking down metabolic vulnerabilities in CDK12 -mutant prostate cancer. Clinical and translational discovery 4 (4) (2024)
Wei-Ling Tu, Mu-En Wang, Ming Chen
Tracking down metabolic vulnerabilities in CDK12 -mutant prostate cancer. Clinical and translational discovery 4 (4) (2024)
Wei-Ling Tu, Mu-En Wang, Ming Chen
Tracking down metabolic vulnerabilities in CDK12 -mutant prostate cancer. Clinical and translational discovery 4 (4) (2024)

volume 3, number 2, 2023

Chennan Li, Anna Baj, Adam G Sowalsky
One toolkit to bring them all, and in silico analyze them. Clinical and translational discovery 3 (2) (2023)

volume 3, number 4, 2023

Carla V Finkielstein, Daniel G S Capelluto
The impact of sulfatide loss on the progress of Alzheimer's disease. Clinical and translational discovery 3 (4) (2023)
Carla V Finkielstein, Daniel G S Capelluto
The impact of sulfatide loss on the progress of Alzheimer's disease. Clinical and translational discovery 3 (4) (2023)
Carla V Finkielstein, Daniel G S Capelluto
The impact of sulfatide loss on the progress of Alzheimer's disease. Clinical and translational discovery 3 (4) (2023)
Carla V Finkielstein, Daniel G S Capelluto
The impact of sulfatide loss on the progress of Alzheimer's disease. Clinical and translational discovery 3 (4) (2023)

volume 3, number 5, 2023

Victor G Kayejo, Hannah Fellner, Roshan Thapa, Peter A Keyel
Translational implications of targeting annexin A2: From membrane repair to muscular dystrophy, cardiovascular disease and cancer. Clinical and translational discovery 3 (5) (2023)
Victor G Kayejo, Hannah Fellner, Roshan Thapa, Peter A Keyel
Translational implications of targeting annexin A2: From membrane repair to muscular dystrophy, cardiovascular disease and cancer. Clinical and translational discovery 3 (5) (2023)

volume 3, number 6, 2023

Doug A Gouchoe, Bryan A Whitson, Hua Zhu
The Next Frontier in Lung Transplantation: Protecting the Endothelium and Repairing Organs for Transplant Utilizing MG53. Clinical and translational discovery 3 (6) (2023)
Doug A Gouchoe, Bryan A Whitson, Hua Zhu
The Next Frontier in Lung Transplantation: Protecting the Endothelium and Repairing Organs for Transplant Utilizing MG53. Clinical and translational discovery 3 (6) (2023)
Doug A Gouchoe, Bryan A Whitson, Hua Zhu
The Next Frontier in Lung Transplantation: Protecting the Endothelium and Repairing Organs for Transplant Utilizing MG53. Clinical and translational discovery 3 (6) (2023)

volume 2, number 1, 2022

Baoyi Zhang, Kevin Yao, Chao Cheng
Immune infiltration difference between tumor and adjacent normal regions is prognostic for gastric cancer patients. Clinical and translational discovery 2 (1) (2022)
Teng Liu, Leshan Xiu, Kun Yin, Shengli Li
Dominant mutations in the severe acute respiratory syndrome coronavirus-2 genome challenge polymerase chain reaction detection. Clinical and translational discovery 2 (1) (2022)
Buhai Wang, Jiangquan Yu, Yichun Zeng, Xian Zhang, Chongxu Han, Qili Lu, Xiaolin Wang, Yichen Liang, Juan J Gu, Yusheng Shu
Successful treatment of an 82-year-old COVID-19 delta variant-infected patient with haemorrhagic stroke and active prostate cancer brain metastasis. Clinical and translational discovery 2 (1) (2022)
Christian Carlos Zurita-Lizza, Pablo Alexis Doreski
Potential reversal of pulmonary vasoplegia by inhaled ibuprofenate in COVID-19 pneumonia. Clinical and translational discovery 2 (1) (2022)
Hyok Ju Ri, Xin Chen
The updated strategy to overcome new challenge: Omicron variant (B.1.1.529) pandemic. Clinical and translational discovery 2 (1) (2022)
Harald Walach, Rainer J Klement, Wouter Aukema
The risk-benefit ratio of Covid-19 vaccines: Publication policy by retraction does nothing to improve it. Clinical and translational discovery 2 (1) (2022)

volume 2, number 2, 2022

So Yun Lim, Jiwon Jung, Sung-Han Kim
Preparedness for further boosting coronavirus disease 2019 vaccines. Clinical and translational discovery 2 (2) (2022)
Arpan Acharya, Tatiana G Kutateladze, Siddappa N Byrareddy
Combining antiviral drugs with BET inhibitors is beneficial in combatting SARS-CoV-2 infection. Clinical and translational discovery 2 (2) (2022)
Ian Galea
Microglial heterogeneity after subarachnoid haemorrhage. Clinical and translational discovery 2 (2) (2022)
Saravanakumar Marimuthu, Surinder K Batra, Moorthy P Ponnusamy
Pan-cancer analysis of altered glycosyltransferases confers poor clinical outcomes. Clinical and translational discovery 2 (2) (2022)
Samer Singh, Dhiraj Kishore, Rakesh K Singh, Chandramani Pathak, Kishu Ranjan
Higher BCG-induced trained immunity prevalence predicts protection from COVID-19: Implications for ongoing BCG trials. Clinical and translational discovery 2 (2) (2022)
Abby Lund Da Costa, Het Mehta, Ramkumar Mathur
Promoting autophagy to mitigate coronavirus disease pathology in the elderly. Clinical and translational discovery 2 (2) (2022)
Chunxia Wang, Yucai Zhang
Focusing on the long-term recovery of severe acute respiratory syndrome coronavirus 2 infection: Clinically relevant observations. Clinical and translational discovery 2 (2) (2022)
Manoj Kumar Pandey
Pre-existing humoral immune comebacks control the development of the severe form of coronavirus disease 2019 in Gaucher patients. Clinical and translational discovery 2 (2) (2022)
Wei Yang
Early innate immune responses in different COVID-19 sub-phenotypes through a transcriptomics lens. Clinical and translational discovery 2 (2) (2022)
Sakthijothi Muthu, Sundararajan Venkatesh
A commentary on "PI3K-α/mTOR/BRD4 inhibitor alone or in combination with other anti-virals blocks replication of SARS-CoV-2 and its variants of concern including Delta and Omicron". Clinical and translational discovery 2 (2) (2022)
Samuel D Johnson, Siddappa N Byrareddy
HIV-associated dysbiosis and immune recovery during antiretroviral therapy. Clinical and translational discovery 2 (2) (2022)

volume 2, number 3, 2022

Jia Ju, Kun Sun
Plasma cell-free DNA analysis for COVID-19 and beyond. Clinical and translational discovery 2 (3) (2022)
Mirolyuba Simeonova Ilieva, Max Tschaikowski, Andrea Vandin, Shziuka Uchida
The current status of gene expression profilings in COVID-19 patients. Clinical and translational discovery 2 (3) (2022)
Antonio Cappuccio, Jennifer Geis, Yongchao Ge, Venugopalan D Nair, Naveen Ramalingam, Weiguang Mao, Maria Chikina, Andrew G Letizia, Stuart C Sealfon
Earlier detection of SARS-CoV-2 infection by blood RNA signature microfluidics assay. Clinical and translational discovery 2 (3) (2022)
Jill Comeau, Kavitha Beedupalli, Seetharama Jois
Multiple primary lung cancer tumors with diversified genetic mutations-complications in choosing therapeutic options. Clinical and translational discovery 2 (3) (2022)
Jill Comeau, Kavitha Beedupalli, Seetharama Jois
Multiple primary lung cancer tumors with diversified genetic mutations-complications in choosing therapeutic options. Clinical and translational discovery 2 (3) (2022)

volume 2, number 4, 2022

Jonathan Willman, Matthew Willman, Ramya Reddy, Anna Fusco, Sai Sriram, Yusuf Mehkri, Jude Charles, Joel Goeckeritz, Brandon P Lucke-Wold
Gut microbiome and neurosurgery: Implications for treatment. Clinical and translational discovery 2 (4) (2022)
Zichen Zhang, Jiangang Long, Lingjie Meng, Zhiwei Yang, Shengli Zhang, Lei Zhang
Immune cells-derived exosomes: A promising strategy for COVID-19 treatment. Clinical and translational discovery 2 (4) (2022)
Mirza Ali Mofazzal Jahromi, Mina Sefidfard, Ali Taghipour, Abazar Roustazadeh, Sara Matin, Hamed Mir, Milad Badri, Fares Bahrami, Amir Abdoli
Latent infections, coronavirus disease 2019 and psychiatric disorders: The friend of my enemy. Clinical and translational discovery 2 (4) (2022)
Mirza Ali Mofazzal Jahromi, Mina Sefidfard, Ali Taghipour, Abazar Roustazadeh, Sara Matin, Hamed Mir, Milad Badri, Fares Bahrami, Amir Abdoli
Latent infections, coronavirus disease 2019 and psychiatric disorders: The friend of my enemy. Clinical and translational discovery 2 (4) (2022)
Zichen Zhang, Jiangang Long, Lingjie Meng, Zhiwei Yang, Shengli Zhang, Lei Zhang
Immune cells-derived exosomes: A promising strategy for COVID-19 treatment. Clinical and translational discovery 2 (4) (2022)
Anastasia E Metropulos, Jeffrey H Becker, Daniel R Principe
Chromium (VI) promotes lung cancer initiation by activating EGF/ALDH1A1 signalling. Clinical and translational discovery 2 (4) (2022)
Viviane Nascimento Da Conceicao, Bibhuti B Mishra, Brij B Singh
R(h)oad to antitumour therapy. Clinical and translational discovery 2 (4) (2022)

volume 1, number 1, 2021

Kristian M Hargadon
A call for discovery: Re-envisioning The Cancer Genome Atlas as a blueprint for a TCGA2.0-The COVID-19 Genome Atlas. Clinical and translational discovery 1 (1) (2021)